IL120503A0 - Peptides for the treatment of systemic lupus erythematosis and pharmaceutical compositions containing them - Google Patents

Peptides for the treatment of systemic lupus erythematosis and pharmaceutical compositions containing them

Info

Publication number: IL120503A0
Authority: IL; Israel
Prior art keywords: systemic lupus; peptides; treatment; pharmaceutical compositions; compositions containing
Prior art date: 1997-03-20

Application number

IL12050397A

Other languages

English (en)

Original Assignee

Hadasit Med Res Service

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-20

Filing date

1997-03-20

Publication date

1997-07-13

1997-03-20 Application filed by Hadasit Med Res Service filed Critical Hadasit Med Res Service

1997-03-20 Priority to IL12050397A priority Critical patent/IL120503A0/xx

1997-07-13 Publication of IL120503A0 publication Critical patent/IL120503A0/xx

1998-03-20 Priority to ES98907114T priority patent/ES2279567T3/es

1998-03-20 Priority to AU63065/98A priority patent/AU734444B2/en

1998-03-20 Priority to PT98907114T priority patent/PT972032E/pt

1998-03-20 Priority to DE69836679T priority patent/DE69836679T2/de

1998-03-20 Priority to EP98907114A priority patent/EP0972032B1/fr

1998-03-20 Priority to AT98907114T priority patent/ATE348885T1/de

1998-03-20 Priority to IL13195098A priority patent/IL131950A0/xx

1998-03-20 Priority to DK98907114T priority patent/DK0972032T3/da

1998-03-20 Priority to JP54532898A priority patent/JP4459307B2/ja

1998-03-20 Priority to CA002283792A priority patent/CA2283792A1/fr

1998-03-20 Priority to PCT/IB1998/000415 priority patent/WO1998042737A2/fr

1998-03-20 Priority to NZ337953A priority patent/NZ337953A/en

1999-09-16 Priority to IL131950A priority patent/IL131950A/en

1999-09-20 Priority to US09/399,494 priority patent/US6228363B1/en

2001-04-04 Priority to US09/826,069 priority patent/US20020054872A1/en

Links

201000000596 systemic lupus erythematosus Diseases 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
YIYCUMYWGOOSNU-FMZZOXHWSA-N 2-[[(2s)-1-[(2s,3s)-2-[[(2s,3r)-2-[[2-[[(2s)-2-amino-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O YIYCUMYWGOOSNU-FMZZOXHWSA-N 0.000 abstract 2
102000007547 Laminin Human genes 0.000 abstract 1
108010085895 Laminin Proteins 0.000 abstract 1
238000003556 assay Methods 0.000 abstract 1
238000010352 biotechnological method Methods 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000001575 pathological effect Effects 0.000 abstract 1
238000010189 synthetic method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Transplantation (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)

IL12050397A 1997-03-20 1997-03-20 Peptides for the treatment of systemic lupus erythematosis and pharmaceutical compositions containing them IL120503A0 (en)

Priority Applications (16)

Application Number	Priority Date	Filing Date	Title
IL12050397A IL120503A0 (en)	1997-03-20	1997-03-20	Peptides for the treatment of systemic lupus erythematosis and pharmaceutical compositions containing them
NZ337953A NZ337953A (en)	1997-03-20	1998-03-20	Peptides for the treatment of systemic lupus erythematosus using a laminin peptide , peptides and antibodies therefor
AT98907114T ATE348885T1 (de)	1997-03-20	1998-03-20	Peptide zur behandlung des systemischen lupus erythematosus
DK98907114T DK0972032T3 (da)	1997-03-20	1998-03-20	Peptider til behandling af systemisk lupus erythematosus
PT98907114T PT972032E (pt)	1997-03-20	1998-03-20	Péptidos para o tratamento do lúpos eritematoso agudo disseminado
DE69836679T DE69836679T2 (de)	1997-03-20	1998-03-20	Peptide zur behandlung des systemischen lupus erythematosus
EP98907114A EP0972032B1 (fr)	1997-03-20	1998-03-20	Peptides destines au traitement du lupus erythemateux systemique
ES98907114T ES2279567T3 (es)	1997-03-20	1998-03-20	Peptidos para el tratamiento del lupus erythematosus sistematico.
IL13195098A IL131950A0 (en)	1997-03-20	1998-03-20	Peptides for the treatment of systemic lupus erythematosus
AU63065/98A AU734444B2 (en)	1997-03-20	1998-03-20	Peptides for the treatment of systemic lupus erythematosus
JP54532898A JP4459307B2 (ja)	1997-03-20	1998-03-20	全身性紅斑性狼瘡を治療するためのペプチド
CA002283792A CA2283792A1 (fr)	1997-03-20	1998-03-20	Peptides destines au traitement du lupus erythemateux systemique
PCT/IB1998/000415 WO1998042737A2 (fr)	1997-03-20	1998-03-20	Peptides destines au traitement du lupus erythemateux systemique
IL131950A IL131950A (en)	1997-03-20	1999-09-16	Laminin peptides for the treatment of systemic lupus erythematosus
US09/399,494 US6228363B1 (en)	1997-03-20	1999-09-20	Peptides for the treatment of systemic lupus erythematosus
US09/826,069 US20020054872A1 (en)	1997-03-20	2001-04-04	Peptides for the treatment of systemic lupus erythematosus and methods of treating systemic lupus erythematosus

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IL12050397A IL120503A0 (en)	1997-03-20	1997-03-20	Peptides for the treatment of systemic lupus erythematosis and pharmaceutical compositions containing them

Publications (1)

Publication Number	Publication Date
IL120503A0 true IL120503A0 (en)	1997-07-13

Family

ID=11069947

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL12050397A IL120503A0 (en)	1997-03-20	1997-03-20	Peptides for the treatment of systemic lupus erythematosis and pharmaceutical compositions containing them
IL131950A IL131950A (en)	1997-03-20	1999-09-16	Laminin peptides for the treatment of systemic lupus erythematosus

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL131950A IL131950A (en)	1997-03-20	1999-09-16	Laminin peptides for the treatment of systemic lupus erythematosus

Country Status (13)

Country	Link
US (1)	US6228363B1 (fr)
EP (1)	EP0972032B1 (fr)
JP (1)	JP4459307B2 (fr)
AT (1)	ATE348885T1 (fr)
AU (1)	AU734444B2 (fr)
CA (1)	CA2283792A1 (fr)
DE (1)	DE69836679T2 (fr)
DK (1)	DK0972032T3 (fr)
ES (1)	ES2279567T3 (fr)
IL (2)	IL120503A0 (fr)
NZ (1)	NZ337953A (fr)
PT (1)	PT972032E (fr)
WO (1)	WO1998042737A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6090200A (en) *	1999-07-15	2001-02-05	Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Peptides and their utility in modulation of behavior of cells expressing alpha3beta1 integrins
US7129052B1 (en) *	2000-07-12	2006-10-31	The United States Of America As Represented By The Department Of Health And Human Services	Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins
WO2001061349A1 (fr) *	2000-02-18	2001-08-23	The University Of Tennessee Research Corporation	Detection de depot microbien et reponse immunitaire au niveau de la membrane basale
IL141647A0 (en) *	2001-02-26	2002-03-10	Yeda Res & Dev	Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
EP1594434B1 (fr) *	2003-01-14	2016-09-07	Yeda Research and Development Co.	Formulations parenterales de peptides servant a traiter un lupus erythemateux systemique
KR20050100616A (ko) *	2003-01-14	2005-10-19	테바 파마슈티컬 인더스트리즈 리미티드	전신성 홍반성 낭창의 치료를 위한 펩티드의 비경구 제제
JP2008539169A (ja)	2005-04-19	2008-11-13	イーライリリーアンドカンパニー	疾患における免疫学的介入のための一価および多価合成多糖類抗原
CN101720231A (zh) *	2007-05-24	2010-06-02	哈德西特有限公司	治疗全身性红斑狼疮的肽和治疗全身性红斑狼疮的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5266328A (en) *	1990-08-27	1993-11-30	Regents Of The University Of Minnesota	Laminin a chain polypeptides from the carboxy terminal globular domain
WO1992004914A1 (fr)	1990-09-14	1992-04-02	The Trustees Of The University Of Pennsylvania	Production de peptides bioactifs sur la base de la structure des immunoglobulines
US6013628A (en) *	1994-02-28	2000-01-11	Regents Of The University Of Minnesota	Method for treating conditions of the eye using polypeptides
IL108811A (en) *	1994-03-01	1998-06-15	Hadasit Med Res Service	Immunoassay reagents, kits and methods
US5493008A (en) *	1994-08-15	1996-02-20	The University Of Virginia Patent Foundation	Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain
EP0765660A3 (fr) *	1995-09-28	1998-09-23	Takeda Chemical Industries, Ltd.	Microcapsules contenant des acides 2-pipérazinone-1-yl-acétiques

1997
- 1997-03-20 IL IL12050397A patent/IL120503A0/xx unknown
1998
- 1998-03-20 CA CA002283792A patent/CA2283792A1/fr not_active Abandoned
- 1998-03-20 AT AT98907114T patent/ATE348885T1/de not_active IP Right Cessation
- 1998-03-20 DE DE69836679T patent/DE69836679T2/de not_active Expired - Lifetime
- 1998-03-20 WO PCT/IB1998/000415 patent/WO1998042737A2/fr not_active Ceased
- 1998-03-20 JP JP54532898A patent/JP4459307B2/ja not_active Expired - Fee Related
- 1998-03-20 ES ES98907114T patent/ES2279567T3/es not_active Expired - Lifetime
- 1998-03-20 DK DK98907114T patent/DK0972032T3/da active
- 1998-03-20 PT PT98907114T patent/PT972032E/pt unknown
- 1998-03-20 NZ NZ337953A patent/NZ337953A/en unknown
- 1998-03-20 AU AU63065/98A patent/AU734444B2/en not_active Ceased
- 1998-03-20 EP EP98907114A patent/EP0972032B1/fr not_active Expired - Lifetime
1999
- 1999-09-16 IL IL131950A patent/IL131950A/en not_active IP Right Cessation
- 1999-09-20 US US09/399,494 patent/US6228363B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO1998042737A3 (fr)	1998-11-05
ES2279567T3 (es)	2007-08-16
WO1998042737A2 (fr)	1998-10-01
DK0972032T3 (da)	2007-04-10
EP0972032A2 (fr)	2000-01-19
JP2001524826A (ja)	2001-12-04
ATE348885T1 (de)	2007-01-15
NZ337953A (en)	2002-03-28
EP0972032B1 (fr)	2006-12-20
AU734444B2 (en)	2001-06-14
AU6306598A (en)	1998-10-20
US6228363B1 (en)	2001-05-08
CA2283792A1 (fr)	1998-10-01
DE69836679T2 (de)	2007-10-04
DE69836679D1 (de)	2007-02-01
JP4459307B2 (ja)	2010-04-28
IL131950A (en)	2006-07-05
PT972032E (pt)	2007-03-30

Publication	Publication Date	Title
HUP0003349A2 (hu)	2001-01-29	Mellékpajzsmirigy-hormon peptidanalógok, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
LTIP702A (en)	1995-01-31	A slimming pharmaceutical composition
SI0820303T1 (en)	2003-10-31	PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES
DE69326064D1 (de)	1999-09-23	Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
EP0552256A4 (fr)	1994-04-27
DE59902055D1 (de)	2002-08-22	Zweiteilige kapsel zur aufnahme von pharmazeutischen zubereitungen für pulverinhalatoren
AU6020099A (en)	2000-03-14	Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
IL93360A (en)	1997-04-15	Bactericidal/permeability increasing protein or biologically active analogs thereof and pharmaceutical compositions containing them
NZ236002A (en)	1993-01-27	Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
IE891542L (en)	1989-11-19	Peptides having t cell helper activity
HUP0001293A1 (hu)	2000-08-28	Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására
MX9704030A (es)	1998-02-28	1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
PL329802A1 (en)	1999-04-12	Derivatives of androstene
TW364850B (en)	1999-07-21	Nematocidal compositions
WO1998042737A3 (fr)	1998-11-05	Peptides destines au traitement du lupus erythemateux systemique
EP0783524A4 (fr)	2000-05-17	Peptides et compositions pharmaceutiques les contenant
BR9810452A (pt)	2000-09-05	Nova combinação de medicamentos contra asma
DK0719276T3 (da)	1998-08-10	Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
WO2008142694A3 (fr)	2010-02-25	Peptides pour le traitement du lupus érythémateux systémique et procédé de traitement du lupus érythémateux systémique
DE69816808D1 (de)	2003-09-04	Somatostatin agoniste zur reduzierung von körpergewicht
YU60199A (sh)	2002-09-19	Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
EP1039931A4 (fr)	2001-01-03	Anticorps de recombinaison multivalents destines au traitement d'infections dues au rhinovirus humain (hrv)
HUP9903688A2 (hu)	2000-03-28	Olanzapin alkalmazása az autizmus kezelésére szolgáló gyógyszerkészítmény előállítására
IL122443A0 (en)	1998-06-15	Synthetic peptides and pharmaceutical compositions comprising them
RU95105249A (ru)	1996-10-27	Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения